Allergan PLC (AGN)

Common-Size Income Statement
Quarterly Data

Difficulty: Beginner

Annual Data

Quarterly Data

Allergan PLC, Common-Size Consolidated Income Statement (quarterly data)

	3 months ended	Sep 30, 2018		Jun 30, 2018		Mar 31, 2018		Dec 31, 2017		Sep 30, 2017		Jun 30, 2017		Mar 31, 2017		Dec 31, 2016		Sep 30, 2016		Jun 30, 2016		Mar 31, 2016		Dec 31, 2015		Sep 30, 2015		Jun 30, 2015		Mar 31, 2015		Dec 31, 2014		Sep 30, 2014		Jun 30, 2014		Mar 31, 2014		Dec 31, 2013		Sep 30, 2013		Jun 30, 2013		Mar 31, 2013
	Net revenues
	Cost of sales, excludes amortization and impairment of acquired intangibles including product rights
	Gross profit
	Research and development
	Selling and marketing
	General and administrative
	Amortization
	Goodwill impairments
	In-process research and development impairments
	Loss on assets held for sale
	Asset sales and impairments, net
	Operating income (loss)
	Interest income
	Interest expense
	Other income (expense), net
	Other income (expense), net
	Income (loss) before income taxes and noncontrolling interest
	(Provision) benefit for income taxes
	Net income (loss) from continuing operations, net of tax
	Income (loss) from discontinued operations, net of tax
	Net income (loss)
	(Income) loss attributable to noncontrolling interest
	Net income (loss) attributable to shareholders
	Dividends on preferred shares
	Net income (loss) attributable to ordinary shareholders

	Allergan PLC	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality